These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 35332865)

  • 1. Country-specific approaches to latent tuberculosis screening targeting migrants in EU/EEA* countries: A survey of national experts, September 2019 to February 2020.
    Margineanu I; Rustage K; Noori T; Zenner D; Greenaway C; Pareek M; Akkerman O; Hayward S; Friedland JS; Goletti D; Stienstra Y; Hargreaves S;
    Euro Surveill; 2022 Mar; 27(12):. PubMed ID: 35332865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review.
    Greenaway C; Pareek M; Abou Chakra CN; Walji M; Makarenko I; Alabdulkarim B; Hogan C; McConnell T; Scarfo B; Christensen R; Tran A; Rowbotham N; van der Werf MJ; Noori T; Pottie K; Matteelli A; Zenner D; Morton RL
    Euro Surveill; 2018 Apr; 23(14):. PubMed ID: 29637889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review.
    Greenaway C; Pareek M; Abou Chakra CN; Walji M; Makarenko I; Alabdulkarim B; Hogan C; McConnell T; Scarfo B; Christensen R; Tran A; Rowbotham N; Noori T; van der Werf MJ; Pottie K; Matteelli A; Zenner D; Morton RL
    Euro Surveill; 2018 Apr; 23(14):. PubMed ID: 29637888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for infectious diseases among newly arrived migrants in EU/EEA countries--varying practices but consensus on the utility of screening.
    Kärki T; Napoli C; Riccardo F; Fabiani M; Dente MG; Carballo M; Noori T; Declich S
    Int J Environ Res Public Health; 2014 Oct; 11(10):11004-14. PubMed ID: 25337945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis and latent tuberculous infection screening of migrants in Europe: comparative analysis of policies, surveillance systems and results.
    Kunst H; Burman M; Arnesen TM; Fiebig L; Hergens MP; Kalkouni O; Klinkenberg E; Orcau À; Soini H; Sotgiu G; Zenner D; de Vries G
    Int J Tuberc Lung Dis; 2017 Aug; 21(8):840-851. PubMed ID: 28786791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent approaches in the vaccination of recently arrived migrants to Europe: a survey of national experts from 32 countries, 2017.
    Hargreaves S; Nellums LB; Ravensbergen SJ; Friedland JS; Stienstra Y;
    Euro Surveill; 2018 Oct; 23(41):. PubMed ID: 30326996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migrant tuberculosis screening in the EU/EEA: yield, coverage and limitations.
    Klinkenberg E; Manissero D; Semenza JC; Verver S
    Eur Respir J; 2009 Nov; 34(5):1180-9. PubMed ID: 19880618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review.
    Seedat F; Hargreaves S; Nellums LB; Ouyang J; Brown M; Friedland JS
    Lancet Infect Dis; 2018 Sep; 18(9):e259-e271. PubMed ID: 29778396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for tuberculosis in migrants and visitors from high-incidence settings: present and future perspectives.
    Dobler CC; Fox GJ; Douglas P; Viney KA; Ahmad Khan F; Temesgen Z; Marais BJ
    Eur Respir J; 2018 Jul; 52(1):. PubMed ID: 29794133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis care among refugees arriving in Europe: a ERS/WHO Europe Region survey of current practices.
    Dara M; Solovic I; Sotgiu G; D'Ambrosio L; Centis R; Tran R; Goletti D; Duarte R; Aliberti S; de Benedictis FM; Bothamley G; Schaberg T; Abubakar I; Teixeira V; Ward B; Gratziou C; Migliori GB
    Eur Respir J; 2016 Sep; 48(3):808-17. PubMed ID: 27492827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European policies in the management of tuberculosis among migrants.
    D'Ambrosio L; Centis R; Dara M; Solovic I; Sulis G; Zumla A; Migliori GB
    Int J Infect Dis; 2017 Mar; 56():85-89. PubMed ID: 27836793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries - a model-based cost-effectiveness analysis.
    Marx FM; Hauer B; Menzies NA; Haas W; Perumal N
    BMC Public Health; 2021 Nov; 21(1):2172. PubMed ID: 34836526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivering multi-disease screening to migrants for latent TB and blood-borne viruses in an emergency department setting: A feasibility study.
    Hargreaves S; Nellums LB; Johnson C; Goldberg J; Pantelidis P; Rahman A; Friedland FMedSci JS
    Travel Med Infect Dis; 2020; 36():101611. PubMed ID: 32126293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points.
    Lönnroth K; Mor Z; Erkens C; Bruchfeld J; Nathavitharana RR; van der Werf MJ; Lange C
    Int J Tuberc Lung Dis; 2017 Jun; 21(6):624-637. PubMed ID: 28482956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis.
    Rustage K; Lobe J; Hayward SE; Kristensen KL; Margineanu I; Stienstra Y; Goletti D; Zenner D; Noori T; Pareek M; Greenaway C; Friedland JS; Nellums LB; Hargreaves S;
    Lancet Infect Dis; 2021 Dec; 21(12):1701-1712. PubMed ID: 34363771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strengthening screening for infectious diseases and vaccination among migrants in Europe: What is needed to close the implementation gaps?
    Noori T; Hargreaves S; Greenaway C; van der Werf M; Driedger M; Morton RL; Hui C; Requena-Mendez A; Agbata E; Myran DT; Pareek M; Campos-Matos I; Nielsen RT; Semenza J; Nellums LB; Pottie K;
    Travel Med Infect Dis; 2021; 39():101715. PubMed ID: 32389827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to reach and motivate migrant communities at high risk for TB to participate in a latent tuberculosis infection screening program: a community-engaged, mixed methods study among Eritreans.
    Spruijt I; Haile DT; Erkens C; van den Hof S; Goosen S; Ten Kate A; Teshome H; Karels M; Koenders M; Suurmond J
    BMC Public Health; 2020 Mar; 20(1):315. PubMed ID: 32164637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Migration-related tuberculosis: epidemiology and characteristics of tuberculosis cases originating outside the European Union and European Economic Area, 2007 to 2013.
    Ködmön C; Zucs P; van der Werf MJ
    Euro Surveill; 2016; 21(12):. PubMed ID: 27039665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and cost-effectiveness of screening migrants for active tuberculosis and latent tuberculous infection.
    Zenner D; Hafezi H; Potter J; Capone S; Matteelli A
    Int J Tuberc Lung Dis; 2017 Sep; 21(9):965-976. PubMed ID: 28826445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for active and latent TB among migrants in France.
    Luan L; Fraisse P; Cordel H; Charlois C; Méchaï F; Ibanez G; Hargreaves S; Mechain M; Vignier N
    Int J Tuberc Lung Dis; 2021 Nov; 25(11):903-910. PubMed ID: 34686232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.